Duquesne University
Pittsburgh, Pennsylvania, 15228, United States
NCT Number: NCT07568301
The goal of this pilot study is to determine the initial impact on wellbeing for clients with acquired brain injury and their care partner after engaging in a nature & music-based program facilitated by occupational therapy and music therapy. The main questions it aims to answer are:
* Primary Question: What is the impact on wellbeing for clients with acquired brain injury and their care partner after engaging in a nature & music-based program facilitated by occupational therapy and music therapy? * Secondary Question: What is the feasibility of a four-session nature & music-based wellness program for clients with acquired brain injury and care partner dyads?
* Attendance * Satisfaction * Accessibility * Carryover of Strategies
Participants will complete self-reported surveys before and after completing 4 sessions of a nature & music-based program facilitated by occupational therapy and music therapy.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Pittsburgh, Pennsylvania, 15228, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: First session to end of program approximately 4 weeks.
EUROHIS-QOL 8 is a standardized assessment of general quality of life that assesses four domains of QOL: physical, psychological, social, and environmental. This assessment has been validated for persons with traumatic brain injury (Balalla et al., 2019). This is 5-point scale from "not at all" to "completely." A high total point value indicates a better quality of life rating.
Time frame: First session to end of program approximately 4 weeks.
The 10-item Connor-Davidson Resilience Scale will be administered as a secondary outcome to determine if any impacts are seen after this brief program because of participation. This measure has been used with persons post-traumatic brain injury, stroke, and caregivers. Rating scale goes from 0-4 with higher total scores indicating better resilence.
Time frame: First day to end of program approximately 4 weeks
The 10-item Dyadic Relationship Scale will be administered as a secondary outcome to examine any changes in both positive and negative interactions between individuals with ABI and their care partners after this program (Sebern & Whitlatch, 2007). This is a four point scale with a higher score indicating more negative dyad experiences.
Time frame: Last session, approximately 4 weeks after first session
This measure uses eight questions on a four point Likert-scale strongly agree to strongly disagree to assess participants' overall satisfaction with the program with a maximum score of 32 (Attkisson & Greenfield, 2004). The average score for the group on the CSQ-8 is at least 24.
Time frame: Every week for 4 weeks.
Session attendance will be tracked at every session throughout the program as either present "1" or absent "0". Participants who attend all sessions will have a total of 4.
Time frame: Every week of the program for four weeks.
4-point Likert scale survey will be used to document participants' interest in using the covered strategies in the sessions. Items will not be totaled and scales vary by question.
Time frame: Weekly journal entries for weeks 2,3, and 4.
A self-reported journal includes date, the name of the activity, length, and personnels will be provided for documenting the carryover activities outside of the session time.
Duquesne University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07065916
Acquired Brain Injury (Including Stroke), Brain Damage, Chronic
Calgary, Alberta, Canada
View Trial DetailsNCT06800040
Acquired Brain Injury (Including Stroke), Brain Diseases
Tromsø, Norway
View Trial DetailsNCT07215195
Acquired Brain Injury (Including Stroke), Brain Diseases
Oxford, United Kingdom
View Trial DetailsNCT06774287
Acquired Brain Injury (Including Stroke), Brain Diseases
Arnhem, Gelderland, Netherlands
View Trial Details